BIOCRYST PHARMACEUTICALS INC Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Biocryst Pharmaceuticals Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • Biocryst Pharmaceuticals Inc Other Assets, Noncurrent for the quarter ending September 30, 2024 was $15.6M, a 36.6% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $15.6M +$4.19M +36.6% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $12.5M +$5.51M +79.3% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $13M +$5.92M +83.9% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $13.1M +$6.28M +92.2% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $11.5M +$4.66M +68.6% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $6.95M -$37K -0.53% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $7.05M -$161K -2.23% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $6.81M +$334K +5.16% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $6.8M +$1.61M +30.9% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $6.98M +$3.17M +83.1% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $7.21M +$3.58M +98.8% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $6.47M +$2.67M +70.2% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $5.19M +$1.55M +42.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $3.81M +$93K +2.5% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.63M -$186K -4.88% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $3.8M +$212K +5.91% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $3.65M -$599K -14.1% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $3.72M -$613K -14.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.81M -$1.58M -29.3% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $3.59M +$2.61M +267% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $4.25M +$2.83M +199% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $4.33M +$3.49M +415% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $5.39M +$5.17M +2328% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $978K -$1.05M -51.8% Dec 31, 2018 10-K 2020-03-13
Q3 2018 $1.42M -$535K -27.4% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $841K -$1.03M -55.1% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $222K -$2.05M -90.2% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $2.03M -$1.79M -46.8% Dec 31, 2017 10-K 2019-03-14
Q3 2017 $1.96M -$235K -10.7% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $1.87M +$261K +16.2% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $2.27M -$443K -16.3% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $3.81M -$1.66M -30.3% Dec 31, 2016 10-K 2018-03-12
Q3 2016 $2.19M -$3.05M -58.2% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $1.61M -$4.09M -71.7% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $2.71M -$3.78M -58.2% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $5.47M -$563K -9.34% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $5.24M +$3.96M +310% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $5.7M +$3M +111% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $6.5M +$2M +44.5% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $6.03M +$2.41M +66.6% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $1.28M -$3.8M -74.8% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $2.7M -$3M -52.6% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $4.5M -$1.58M -26% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $3.62M -$5.07M -58.4% Dec 31, 2013 10-K 2015-03-02
Q3 2013 $5.08M -$4.04M -44.3% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $5.7M -$3.01M -34.6% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $6.07M -$1.66M -21.5% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $8.69M +$1.26M +17% Dec 31, 2012 10-K 2014-03-10
Q3 2012 $9.11M +$1.96M +27.3% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $8.7M +$2.01M +30% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $7.73M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $7.43M +$7.43M Dec 31, 2011 10-K 2013-03-11
Q3 2011 $7.16M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 $6.7M Jun 30, 2011 10-Q 2011-08-04
Q4 2010 $0 Dec 31, 2010 10-K 2012-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.